Professor of Urology, Wayne State University
Urology
Isaac J. Powell, MD works in the field of Urology. He went to medical school at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. He over the years received 11 awards: "Regional Top Doctor", "Best Doctors", "Ambassador Award", "Healthcare Heros: Outstanding Physician Achievement Award", "Americas Top Physicians", "American Cancer Award", "Karmanos Partner Award", "Presidents Achievement Award for Community Research", "The Patient Medical Professional Advocate Award", "Michiganian of The Year Award" and "Fellow (FACS)". Dr. Isaac J. Powell has written publications. He has 92 publications published with PubMed. The lastest paper is: 'Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: a study comparing African Americans and whites.' Isaac J. Powell is registered with Medicare.
Publications
- Re: Early Detection of Prostate Cancer: AUA guideline: H. B. Carter, P. C. Albertsen, M. J. Barry, R. Etzioni, S. J. Freedland, K. L. Greene, L. Holmberg, P. Kantoff, ...
- HOXB13 is a susceptibility gene for prostate Cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
- Genes associated with prostate Cancer are differentially expressed in african american and European american men.
- Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM.
- The precise role of ethnicity and family history on aggressive prostate Cancer: a review analysis.
- Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate Cancer in black than in white American men, and influences raci...
- Interplay of race, socioeconomic status, and treatment on survival of patients with prostate Cancer.
- Epidemiology, pathology, and genetics of prostate Cancer among African Americans compared with other ethnicities.
- Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate Cancer risk in African American familial and sporadic cases.
- A randomized trial comparing web-based decision aids on prostate Cancer knowledge for African-American men.
- A decision aid for teaching limitations of prostate Cancer screening.
- The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate Cancer.
- Knowledge of hereditary prostate Cancer among high-risk African American men.
- Epidemiology and pathophysiology of prostate Cancer in African-American men.
- Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate Cancer among white and African-American men.
- The impact of CAG repeats in exon 1 of the androgen receptor on disease progression after Prostatectomy.
- Vitamin D receptor gene polymorphisms and disease free survival after radical Prostatectomy.
- CYP3A4 genetic variant and disease-free survival among white and black men after radical Prostatectomy.
- The effect of race/ethnicity on prostate Cancer treatment outcome is conditional: a review of Wayne State University data.
- Radical Prostatectomy nomograms in black American men: accuracy and applicability.
- Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate Cancer.
- Neoadjuvant therapy before radical Prostatectomy for clinical T3/T4 carcinoma of the Prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.
- Prostate Cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
- Presence of circulating prostate Cancer cells in African American males adversely affects survival.
- Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate Cancer: a multivariable analysis.
- Prostate specific antigen progression after radical Prostatectomy in African-American men versus white men.
- Results from a prostate Cancer admixture mapping study in African-American men.
- African-American race is a predictor of prostate Cancer detection: incorporation into a pre-biopsy nomogram.
- Biochemical recurrence after radical prostatectomy in black and white American men with a positive or negative family history of prostate Cancer.
- Racial differences and prognostic significance of tumor location in radical Prostatectomy specimens.
- Population-based study of pelvic lymph node positivity in clinically localized prostate Cancer: a study comparing African Americans and whites.
- Should African-American men be tested for Prostate carcinoma at an earlier age than white men?
- Should the age specific Prostate specific antigen cutoff for Prostate biopsy be higher for black than for white men older than 50 years?
- Prostate Cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
- Impact of location and multifocality of positive surgical margins on disease-free survival following radical Prostatectomy: a comparison between African-American and w...
- Gleason score 7 prostate Cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival.
- Removal of the financial barrier to health care: does it impact on prostate Cancer at presentation and survival? A comparative study between black and white men in a V...
- Value of preoperative PSA in predicting pathologic stage of patients undergoing salvage Prostatectomy.
- The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate Cancer: a multivariate analysis of positive surgical mar...
- Outcome of African American men screened for prostate Cancer: the Detroit Education and Early Detection Study.
- Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate Cancer.
- A similar pattern of chromosomal alterations in prostate Cancers from African-Americans and Caucasian Americans.
- Effect of neoadjuvant androgen deprivation on circulating Prostate cells in the bone marrow of men undergoing radical Prostatectomy.
- 8pter-p23 deletion is associated with racial differences in prostate Cancer outcome.
- African American men and hereditary/familial prostate Cancer: Intermediate-risk populations for chemoprevention trials.
- Lycopene and soy isoflavones in the treatment of prostate Cancer.
- Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate Cancer.
- Flow cytometric DNA analysis of fresh prostatic resections. Correlation with conventional prognostic parameters in patients with prostate Cancer.
- African-American heredity prostate Cancer study: a model for genetic research.
- Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate Cancer.
- Keynote address: prostate Cancer among African-American men--from the bench to the community.
- Digital rectal examinations and prostate Cancer screening: attitudes of African American men.
- Genome-wide linkage analysis of 1,233 prostate Cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.
- Interest in genetic prostate Cancer susceptibility testing among african American men.
- Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
- Results of a clinical care pathway for radical Prostatectomy patients in an open hospital - multiphysician system.
- Epigenetic silencing of miR-34a in human prostate Cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.
- Stability of self-reported family history of prostate Cancer among African American men.
- Racial disparities in prostate Cancer incidence, biochemical recurrence, and mortality.
- Differential growth factor responses of epithelial cell cultures derived from normal human Prostate, benign prostatic hyperplasia, and primary Prostate carcinoma.
- Prostate Cancer and African-American men.
- Prostate Cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.
- Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate Cancer.
- Considering race and the potential for ERG expression as a biomarker for prostate Cancer.
- Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis.
- Early detection issues of prostate Cancer in African American men.
- Prostate Cancer in the African American: is this a different disease?
- Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC).
- A comparison of the W-stapled ileal reservoir with hand-sewn reservoirs for orthotopic Bladder replacement.
- A common nonsense mutation in EphB2 is associated with prostate Cancer risk in African American men with a positive family history.
- Prostate Cancer in African American men: increasing knowledge and self-efficacy.
- Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate Cancer families collected by the ICPCG.
- Race, biochemical disease recurrence, and Prostate-specific antigen doubling time in the SEARCH database.
- Clinical characteristics of African-American men with hereditary prostate Cancer: the AAHPC Study.
- Acquired rectoUrethral fistula: methods of repair.
- Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability.
- Loss of the 17p chromosomal region in a metastatic carcinoma of the Prostate.
- Compelling evidence for a prostate Cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.
- Validation of a food frequency questionnaire measurement of selected nutrients using biological markers in African-American men.
- Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study.
- High-grade intra-epithelial neoplasia and prostate Cancer in Dibombari, Cameroon.
- Apparent correlation of sex chromosome loss and disease course in urothelial Cancer.
- Villous adenoma and adenocarcinoma of Female urethra.
- Fibrosarcoma of Kidney.
- Re: The importance of marker chromosomes in superficial transitional cell carcinoma of the Bladder: 50 patients followed up to 17 years.
- A new approach in the diagnosis and follow-up of Bladder cancer. FISH analysis of urine, Bladder washings, and tumors.
- Cytogenetic studies of carcinoma in situ of the Bladder: prognostic implications.
- Multiple medication use in the elderly. Use of prescription and non-prescription drugs in an Australian community setting.
- The Dubbo study of the health of elderly: correlates of coronary heart Disease at study entry.
- The Dubbo study: an Australian prospective community study of the health of elderly.
- Dubbo study of the elderly: sociological and cardiovascular risk factors at entry.
Schools
Indiana University School Of Medicine
Henry Ford Hospital
Procedures Preformed
- Cystometry
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Prostate Removal
- TURP (TransUrethral Resection of Prostate) or Laser Destruction of Prostate
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
Accepted Insurances
Awards
- Regional Top Doctor
- Best Doctors
- Ambassador Award
- “Healthcare Hero’sâ€Â: Outstanding Physician Achievement Award
- America’s Top Physicians
- American Cancer Award
- Karmanos Partner Award
- President’s Achievement Award for Community Research
- The Patient Medical Professional Advocate Award
- Michiganian of The Year Award
- Fellow (FACS)
Education
-
Henry Ford Hospital - Wayne State University
-
Indiana University School of Medicine
-
University of Michigan
Hospital
-
DMC - Detroit Receiving Hospital
-
DMC Harper University Hospital
Drug Facts
| NPI NUMBER |
|
1154361608 |
| NPPES Provider LastName |
|
POWELL |
| NPPES Provider FirstName |
|
ISAAC |
| NPPES Provider ZIPCode |
|
482012013 |
| NPPES Provider State |
|
MI |
| Specialty Description |
|
Urology |
| Total Claim Count |
|
193.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1154361608 |
| Last Name Of The Provider |
POWELL |
| First Name Of The Provider |
ISAAC |
| View All |
|
Similar Doctors
|
Dr. Bijan Shekarriz, MD
|
|
|
Dr. Kenneth A. Brown, MD
|
|
|
Dr. Abd-El-Rahman M. Abd-El-Barr, MD
|
|
|
Dr. Nazia Q. Bandukwala, DO
|
|
|
Dr. Shopana Ganpath, MD
|
|
|
Dr. Lewis J. Johnson, DO
|
|
|
Dr. Zachary J. Liss, MD
|
|
|
Dr. Frank J. Penna III, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay Jhaveri, MD
|
|
|
Dr. David L. Weatherly, MD
|
|
|
Dr. Jesse D. Sammon, DO
|
Doctor Directory | TOS | twitter | FB | Angel | blog